Neimeth Worldwide Prescribed drugs Plc has seen its share worth soar by over 45% week-to-date on the Nigerian Trade following its 66th Annual Common Assembly (AGM), the place capital-raising and growth plans had been adopted.
On the AGM on Monday, June 23, shareholders permitted a plan permitting the corporate’s administrators to lift as much as N20 billion by issuing shares, a transfer aimed toward strengthening its capital base.
Shareholders had been additionally instructed that Neimeth redirected N1.5 billion initially meant for a brand new plant in Anambra to develop its current manufacturing facility in Lagos, with the Chairman noting that updates can be offered because the mission progresses.
Additionally on the assembly, shareholders permitted the 2024 audited accounts, which confirmed that the pre-tax loss dropped from N1.6 billion to N854.4 million, supported by N4.4 billion in income from pharmaceutical gross sales.
Following these developments, Neimeth’s shares rose by 10.00% on Monday, June 23, topping the NGX advancers’ chart. By June 26, the inventory had gained over 45%, closing at N5.40 from the week’s open of N3.80.
Neimeth’s shares started the 12 months at N2.29 and closed January at N2.65, buying and selling on a quantity of 54.4 million shares. The bullish momentum continued into February, lifting the inventory above the N3 mark.
As of the shut of buying and selling on June 26, Neimeth shares are up 45.95% for the week, buying and selling at N5.40, with a month-to-date achieve of 74%.
Along with routine issues akin to adopting the 2024 audited financials, appointing and re-electing administrators, and setting remuneration, shareholders additionally permitted a number of key resolutions:
